Work

Preclinical Studies for Sickle Cell Disease Gene Therapy Using Bone Marrow CD34+ Cells Modified with a βAS3-Globin Lentiviral Vector

Year: 2011

Type: article

Source: Blood

DOI: 10.1182/blood.v118.21.3119.3119

Authors: Fabrizia Urbinati, Zulema Romero Garcia, Sabine Geiger, Rafael Ruiz de Assin, Gabriela Kuftinec, Roger P. Hollis, Satiro N. De Oliveira, Jennifer Wherley, Aaron Cooper, Tim M. Townes, Gay M. Crooks, Elizabeth J Read, Mark C. Walters, Herbert J. Meiselman, Thomas D. Coates, Victor J. Marder, Donald B. Kohn

Institutions: University of California, Los Angeles, University of Alabama at Birmingham, University of California, San Francisco, Children's Hospital Los Angeles

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980417133

FWCI:

Cites:

Cited by:

Related to: 10